Key opinion leaders previously interviewed by GlobalData noted the need for more data on current RSV vaccines and their use ...

Within the paediatric age group with access to vaccines, cumulative rates of Covid-19-associated hospitalisations were ...

Immunogenicity is a measure of the immune response to a biotherapeutic drug. It is a very relevant issue affecting not only the use of therapeutic protein drugs such as mAbs but also peptides, enzymes ...

Moderna (MRNA) announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, October 19-22, 2025, in ...

Scientists working for Novartis have taken a step forward in better understanding how new classes of biological drugs might affect patients’ immune systems. Paul Wassmann, PhD senior principal ...

Assessing the immunogenicity, the ability of a foreign substance to elicit an immune response, of any drug or therapeutic is essential to assessing efficacy and toxicity at the early stages of drug ...

The Ad26.COV2.S vaccine, which was approved as a single-shot immunization regimen, has been shown to be effective against severe coronavirus disease 2019. However, this vaccine induces lower severe ...

The first patents of recombinant-DNA-derived biopharmaceuticals will expire in the near future, which should allow the marketing of 'generics'. With classical drugs, generics can be marketed on the ...

A recent study under review at the Journal of Clinical Immunology and currently available on the preprint server Research Square* analyzes the contribution of antibodies against the severe acute ...